Comorbidities in Idiopathic Pulmonary Fibrosis: A Clinical Resource Guide
Jointly provided by:
You must read the entire PDF to claim credit.
Note: If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. Access the site directly or scan the bar code on the back of this publication. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13651. Upon registering and successfully completing the post-test with a score of 80% or better and the activity evaluation, your certificate will be made available immediately.
Upon completing this activity, the participant should be better able to:
- Describe comorbidities commonly occurring in IPF patients
- Apply strategies to diagnose comorbidities in IPF patients
- Employ best practices for engaging other members of the healthcare team when managing comorbidities
- Review optimal treatment approaches to comorbidities in IPF patients
- Apply strategies to engage patients in shared decision-making regarding the management of their comorbidities and IPF care
Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Catamount Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Timothy Blackwell, MD: Contracted Research: Boehringer Ingelheim, Celgene
Planners and Managers: PIM planners and managers have nothing to disclose. Catamount Medical Education planners and managers have nothing to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period March 15, 2019 through March 15, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. Access the site directly or scan the bar code on the back of this publication. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13651. Upon registering and successfully completing the post-test with a score of 80% or better and the activity evaluation, your certificate will be made available immediately.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Minimum System Requirements
The following system requirements are recommended for the best presentation viewing experience:
- Microsoft Windows Vista, Windows 7, or Mac OS X Mavericks, Yosemite, El Capitan
- Display resolution of 1024 × 768 or greater
- Sound card
- Microsoft Internet Explorer 9 or higher on Windows
- Safari 7 and higher on Mac
- Chrome 46 and higher on Windows/Mac
- Firefox 41 and higher on Windows/Mac
- Broadband Internet connection
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient‘s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer‘s product information, and comparison with recommendations of other authorities.
CHEST® Physician is pleased to distribute this informational resource for pulmonary, critical care, and sleep medicine physicians; cardiothoracic surgeons; cardiovascular surgeons; and cardiologists, but this distribution does not convey endorsement and is not intended to replace professional medical care and physician advice, which always should be sought for any specific condition. CHEST and its officers, regents, members, and employees disclaim all liability for the accuracy or completeness of the content and disclaim all warranties, express or implied.
Copyright © 2019 by Global Academy for Medical Education, LLC, Frontline Medical Communications Inc., and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC and Frontline Medical Communications will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.